Abstract
Radiofrequency renal denervation (RFāRDN) decreases blood pressure (BP) in patients with drugāresistant hypertension. This study investigated the effects of RFāRDN on sympathetic activity and BP (Systolic, SBP; Diastolic, DBP) in SHR. Methods Nineteenāweek old male SHR were instrumented with telemetry probes for chronic measurement of BP and BP variability (BPV). After 1āweek, control BP was measured in rats for 3 days. The next day SHR (n=6/group) were anesthetized and randomly received either bilateral ShamāRDN or RFāRDN of the renal arteries (Biosense Webster Stockert 70 generator and RFāprobe). BP was then measured in SHR for 8 weeks. Results Following RFāRDN, SBP/DBP was significantly decreased the day after (153Ā±8/102Ā±4 mmHg) and throughout the postāRDN study (4āweek SBP/DBP, 173Ā±7/120Ā±5; 8āweeks, 171Ā±6/116Ā±4 mmHg) compared to preāRDN control levels (SBP/DBP, 187Ā±9/130Ā±5 mmHg). RFāRDN significantly decreased the low frequency component of BPV in SHR with the peak attenuation observed at 8 weeks (LF/HF 2.2Ā±0.2 vs 0.9Ā±0.2); this correlated with a blunting of the hypotensive response to i.p. chlorisondamine in RFāRDN rats. Finally, at the end of week 8, kidney norepinephrine (NE) levels in RFāRDN rats (left, 10Ā±10; right, 0.0Ā±0.0 ng/g kidney) were dramatically decreased compared with levels from sham SHR (left, 130Ā±10; right, 110Ā±10 ng/g kidney). Conclusions These data demonstrate that in hypertensive SHR, bilateral RFāRDN of the renal arteries decreases BP in part by chronic inhibition of sympathetic neural pathways and a decrease in renal tissue NE levels.Grant Funding Source: Biosense Webster grant IISā175 to DRK and FS; NIH NIGMS P20 GM103514 to DK
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have